Elevated placental growth factor levels are associated with adverse outcomes at four-year follow-up in patients with acute coronary syndromes

Journal of the American College of Cardiology

Volumn 47, Issue 2, 2006, Pages 307-311

  Lenderink, Timo ^a,b   Heeschen, Christopher ^c   Fichtlscherer, Stephan ^d   Dimmeler, Stefanie ^d   Hamm, Christian W ^e   Zeiher, Andreas M ^d   Simoons, Maarten L ^a   Boersma, Eric ^a  

^a Sittard Geleen Heerlen   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^d GOETHE UNIVERSITY   (Germany)

^e KERCKHOFF HEART CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; CD40 LIGAND; PLATELET DERIVED GROWTH FACTOR; TROPONIN T;

ACUTE CORONARY SYNDROME; ARTICLE; CARDIAC PATIENT; CONTROLLED STUDY; DISEASE MARKER; FOLLOW UP; HEART INFARCTION; HEART MUSCLE NECROSIS; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION;

ANGINA, UNSTABLE; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CD40 LIGAND; CREATINE KINASE; CREATINE KINASE, MB FORM; GROWTH SUBSTANCES; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; MULTIVARIATE ANALYSIS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PLATELET AGGREGATION INHIBITORS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; PREDICTIVE VALUE OF TESTS; PREGNANCY PROTEINS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RANDOMIZED CONTROLLED TRIALS; RISK ASSESSMENT; TROPONIN T;

EID: 30344455356     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.08.063     Document Type: Article

References (17)

1. J. Danesh, P. Whincup, M. Walker Low grade inflammation and coronary heart disease prospective study and updated meta-analyses BMJ 321 2000 199 204
2. F. Haverkate, S.G. Thompson, S.D.M. Pyke, J.R. Gallimore, M.B. Pepys European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group Production of C-reactive protein and risk of coronary events in stable and unstable angina Lancet 349 1997 462 466
3. E. Lindmark, E. Diderholm, L. Wallentin, A. Siegbahn Relationship between interleukin 6 and mortality in patients with unstable coronary artery disease effects of an early invasive or noninvasive strategy JAMA 286 2001 2107 2113
4. G. Liuzzo, L.M. Biasucci, J.R. Gallimore The prognostic value of C-reactive protein and serum amyloid a protein in severe unstable angina N Engl J Med 331 1994 417 424
5. A. Luttun, M. Tjwa, L. Moons Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1 Nat Med 8 2002 831 840
6. C. Heeschen, S. Dimmeler, S. Fichtlscherer CAPTURE Investigators Prognostic value of placental growth factor in patients with acute chest pain JAMA 291 2004 435 441
7. T. Lenderink, E. Boersma, C. Heeschen CAPTURE Investigators Elevated troponin T and C-reactive protein predict impaired outcome for 4 years in patients with refractory unstable angina, and troponin T predicts benefit of treatment with abciximab in combination with PTCA Eur Heart J 24 2003 77 85
8. Y.X. Zhang, W.J. Cliff, G.I. Schoefl, G. Higgins Coronary C-reactive protein distribution its relation to development of atherosclerosis Atherosclerosis 145 1999 375 379
9. The CAPTURE Investigators Randomised placebo-controlled trial of abciximab before and during coronary intervention in refractory unstable angina the CAPTURE study Lancet 349 1997 1429 1435
10. C. Heeschen, C.W. Hamm, B. Goldmann, A. Deu, L. Langenbrink, H.D. White PRISM Study Investigators Troponin concentrations for stratification of patients with acute coronary syndromes in relation to therapeutic efficacy of tirofiban Lancet 354 1999 1757 1762
11. C.W. Hamm, C. Heeschen, B. Goldmann c7E3 Fab Antiplatelet Therapy in Unstable Refractory Angina (CAPTURE) Study Investigators Benefit of abciximab in patients with refractory unstable angina in relation to serum troponin T levels N Engl J Med 340 1999 1623 1629
12. C. Heeschen, S. Dimmeler, C.W. Hamm Soluble CD40 ligand in acute coronary syndromes N Engl J Med 348 2003 1104 1111
13. L.M. Biasucci, G. Liuzzo, C. Colizzi, V. Rizzello Clinical use of C-reactive protein for the prognostic stratification of patients with ischemic heart disease Ital Heart J 2 2001 164 171
14. P.M. Ridker, M. Cushman, M.J. Stampfer, R.P. Tracy, C.H. Hennekens Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men N Engl J Med 336 1997 973 979
15. L.M. Biasucci, G. Liuzzo, R.L. Grillo Elevated levels of C-reactive protein at discharge predict recurrent instability Circulation 99 1999 855 860
16. M.C. Tataru, J. Heinrich, R. Junker C-reactive protein and the severity of atherosclerosis in myocardial infarction patients with stable angina pectoris Eur Heart J 21 2000 1000 1008
17. A. Luttun, M. Tjwa, P. Carmeliet Placental growth factor (PlGF) and its receptor Flt-1 (VEGFR-1) novel therapeutic targets for angiogenic disorders Ann N Y Acad Sci 979 2002 80 93